Thank you so much for your hard work on this issue and your leadership on so many other efforts. I can certainly identify with the comments that you've made and that the gentlelady, my fellow colleague from Alabama, has made. We've seen an uptick certainly in my district of these numbers of notices and penalties that the aggregates businesses, for example, in my district receive, oftentimes for petty little issues. And it seems that there has been an increase in the enforcement from this administration on some things where frankly you ought to have these agencies working with our businesses, helping them come into compliance, consulting with them, doing even a little cost-benefit analysis on the ground level. We've lost all sense of perspective. I have to say as someone who has just been here for a year and a half, I've been a little surprised by a number of things, but perhaps it was my own naivete that led me to expect most of my constituents' concerns would be related to how we should vote on a given matter. {time} 2010 Vote ``no'' on this resolution. Vote ``yes'' on that given bill. But instead, so much of what I have heard over the last 1\1/2\ years has been, as much as anything else: Stop this regulation from being enforced. It's really killing our business. It's hurting job creation right here in our part of the country. How can you rein in these executive mandates? So I've tried to do my part, and others have here as well.…
Todd Young: “Thank you so much for your hard work on this issue and your leadership on so many other efforts. I can certainly…”
Share
More from Todd Young
If we want small businesses to succeed in the long term, we also need to ensure that entrepreneurs have access to capital, a skilled workforce, and a regulatory environment that supports innovation and growth.
This project will create good-paying jobs, strengthen our national and economic security, and ensure the technologies of the future are developed and manufactured here in the United States.
If we cede global biotechnology leadership to China, we risk a future where high-skilled biotech jobs migrate abroad, first-in-class therapies do not reach American patients first, and pharmaceutical supply chains are strategically…
I supported this legislation because the stakes are too high to stand still, and I will continue advocating for a transparent, disciplined approach to implementing these authorities.





